Transmittance spectra and theoretical sun protection factors for a series of sunscreen-containing sun care products

Photodermatology Photoimmunology and Photomedicine

Volumn 15, Issue 2, 1999, Pages 75-80

  Rosenstein, Barry S ^a,b   Weinstock, M A ^a   Habib, R ^b  

^a Department of Community Medicine ^*

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

CIE erythema effectiveness spectra; Spectrophotometry; Sunscreens; Transmittance spectra

Indexed keywords

4 DIMETHYLAMINOBENZOIC ACID 2 ETHYLHEXYL ESTER; 4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; ANTHRANILIC ACID METHYL ESTER; AVOBENZONE; CAMPHOR DERIVATIVE; HOMOSALATE; OXYBENZONE; SALICYLIC ACID OCTYL ESTER; SUNSCREEN; TITANIUM DIOXIDE;

ARTICLE; ERYTHEMA; PRIORITY JOURNAL; SPECTROPHOTOMETRY; ULTRAVIOLET A RADIATION;

EID: 0032909934     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.1999.tb00060.x     Document Type: Article

References (32)

1. Australian/New Zealand UV Transmittance Standard (AS/ NZS 2604:1993).
2. Madronich S. UV radiation in the natural and perturbed atmosphere. In: Tevini M, ed. UV-B radiation and ozone depletion. Boca Raton, FL: Lewis Publishers, 1993: 17-70.
3. McKinlay AF, Diffey BL. A reference spectrum for ultraviolet induced erythema in human skin. Comm Int D'Eclairage J 1987: 6: 17-22.
4. Tyrrell RM. The molecular and cellular pathology of solar ultraviolet radiation. Mol Aspects Med 1994: 15: 1-77.
5. Siegel S. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill, 1956.
6. Cole CA, Van Fossen R. Testing UVA protective agents in man. In: Urbach F, ed. Biological responses to ultraviolet A radiation. Overland Park, KS: Valdenmar Publishing Company, 1992: 335-345.
7. Sayre RM, Agin PP, Le Vee GJ, Marlowe E. A comparison of in vivo and in vitro testing of sunscreening formulas. Photochem Photobiol 1979: 29: 559-566.
8. United States Department of Health, Education and Welfare/Food and Drug Administration. Sunscreen drug products for over-the-counter use. Fed Reg 1978: 43: 38206-38269.
9. Jass HE. The sunscreen industry in the United States: past, present, and future. In: Lowe NJ, Shaath NA, eds. Sunscreen: Development, evaluation, and regulatory aspects. New York: Marcel Dekker, 1990: 149-166.
10. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993: 329: 1147-1151.
11. Naylor MF, Boyd A, Smith DW, Cameron G, Hubbard D, Neldner KH. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol 1995: 131: 170-175.
12. Naylor MF, Farmer KC. Case for sunscreens: A review of their use in preventing actinic damage and neoplasia. Arch Dermatol 1997: 133: 1146-1154.
13. De Gruijl FR, Sterenborg HJCM, Forbes PD et al. Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice. Cancer Res 1993: 53: 53-60.
14. Lavker RM, Veres DA, Irwin CJ, Kaidbey KH. Quantitative assessment of cumulative damage from repetitive exposures to suberythemogenic doses of UVA in human skin. Photochem Photobiol 1995: 62: 348-352.
15. Lavker RM, Gerberick GF, Veres D, Irwin CJ, Kaidbey KH. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. J Am Acad Dermatol 1995: 32: 53-62.
16. Lowe NJ, Meyers DP, Wieder JM et al. Low doses of repetitive ultraviolet A induce morphologic changes in human skin. J Invest Dermatol 1995: 105: 739-743.
17. Kligman KH, Akin FJ, Kligman AM. The contributions of UVA and UVB to connective tissue damage in hairless mice. J Invest Dermatol 1985: 93: 210-214.
18. Bissett DL, Hannon DR, Orr TV. Wavelength dependence of histological, physical, and visible changes in chronically UV-irradiated hairless mouse skin. Photochem Photobiol 1989: 50: 763-769.
19. Kligman LH, Sayre RM. An action spectrum for ultraviolet induced elastosis in hairless mice: quantification of elastosis by image analysis. Photochem Photobiol 1991: 53: 237-242.
20. Setlow RB, Woodhead AD, Grist E. Animal model for ultraviolet radiation-induced melanoma: Platyfish-swordtail hybrid. Proc Natl Acad Sci USA 1989: 86: 8922-8926.
21. Setlow RB, Grist E, Thompson K, Woodhead AD. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci USA 1993: 90: 6666-6670.
22. Setlow RB, Woodhead AD. Temporal changes in the incidence of malignant melanoma: Explanation from action spectra. Mutat Res 1994: 307: 365-373.
23. Ley RD, Applegate LA, Padilla RS, Stuart TD. Ultraviolet radiation-induced malignant melanoma in Monodelphis domestica. Photochem Photobiol 1989: 50: 1-5.
24. Ley RD. Ultraviolet radiation A-induced precursors of cutaneous melanoma in Monodelphis domestica. Cancer Res 1997: 57: 3682-3684.
25. Graham S, Marshall J, Haughey B et al. An inquiry into the epidemiology of melanoma. Am J Epidemiol 1985: 122: 606-619.
26. Garland CF, Garland FC, Gorham ED. Could sunscreens increase melanoma risk? Am J Public Health 1992: 82: 614-615.
27. Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res 1995: 5: 59-65.
28. Urbach F. Ultraviolet A transmission by modern sunscreens: is there a real risk? Photochem Photoimmunol Photomed 1992: 9: 237-241.
29. Weinstock MA. The role of sunscreen lotions in melanoma prevention. In: Grob JJ, Stern RS, MacKie RM, Weinstock MA, eds. Epidemiology, causes and prevention of skin diseases. New York: Blackwell Science Limited, 1997: 159-163.
30. Zhang X, Rosenstein BS, Wang Y, Lebwohl M, Mitchell D, Wei H. Induction of 8-oxo-7,8-dihydro-2′-deoxyguanosine by ultraviolet radiation in calf thymus DNA and HeLa cells. Photochem Photobiol 1997: 65: 119-124.
31. Rosenstein BS, Ducore JM. Induction of DNA strand breaks in normal human fibroblasts exposed to monochromatic ultraviolet and visible wavelengths in the 240-546 nm range. Photochem Photobiol 1983: 38: 51-55.
32. Peak JG, Peak MJ, Sikorski RS, Jones CA. Induction of DNA-protein crosslinks in human cells by ultraviolet and visible radiations: action spectrum. Photochem Photobiol 1985: 41: 295-302.